Related Experiment Video

Updated: Aug 20, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

[Adult patients with congenital heart abnormalities: present and future]

H Kaemmerer1, J Hess

  • 1Klinik für Kinderkardiologie und angeborene Herzfehler, Deutsches Herzzentrum München, Klinik an der Technischen Universität. Kaemmerer@dhm.mhn.de

Deutsche Medizinische Wochenschrift (1946)
|January 15, 2005
PubMed

Insights

Advances in treatment have significantly reduced congenital heart disease mortality, allowing over 80% of affected children to reach adulthood. Lifelong monitoring and multidisciplinary care are crucial for managing residual issues in adults with congenital heart anomalies.

Area of Science:

  • Cardiology
  • Pediatric Cardiology
  • Cardiac Surgery

Context:

  • Congenital heart disease (CHD) incidence is 8-10 per 1000 live births.
  • Medical and surgical advancements have decreased CHD mortality from 80% to 20%.
  • Over 80% of children with CHD now survive into adulthood, with approximately 150,000 adults living with significant congenital heart anomalies in Germany.

Purpose:

  • To highlight the evolving landscape of congenital heart disease management.
  • To emphasize the necessity of lifelong, specialized follow-up care for adults with CHD.
  • To underscore the importance of a multidisciplinary approach in managing complex congenital heart defects.

Summary:

  • Significant progress in pediatric heart surgery, medical treatments, and interventional cardiology has dramatically improved survival rates for congenital heart disease.
  • While curable in some cases (e.g., patent Ductus Botalli, small atrial septal defects), most congenital heart defects require ongoing monitoring due to potential residual issues or sequelae.
  • The growing population of adults with congenital heart anomalies necessitates continuous, specialized care from childhood through adulthood, involving a coordinated effort among various medical specialists.

Impact:

  • Improved survival rates and quality of life for individuals with congenital heart disease.
  • Increased demand for specialized adult congenital heart disease (ACHD) programs and long-term care strategies.
  • Necessity for interdisciplinary collaboration among cardiologists, pediatric cardiologists, cardiac surgeons, and other healthcare professionals for optimal patient outcomes.

More Related Videos

Creation of Patient-Specific Silicone Cardiac Models with Applications in Pre-surgical Plans and Hands-on Training09:15

Creation of Patient-Specific Silicone Cardiac Models with Applications in Pre-surgical Plans and Hands-on Training

Published on: February 10, 2022

A Simplified Model for Heterotopic Heart Valve Transplantation in Rodents06:33

A Simplified Model for Heterotopic Heart Valve Transplantation in Rodents

Published on: September 21, 2021

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...